Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2016

Feb 3, 2016

29745_dirs_2016-02-03_3d95b034-fe9b-4d6f-bda0-959d34e8a496.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2016-02-01

Reporting Person: Crowe Maria A (President, Mfg. Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-01 Common Stock M 7252 Acquired 85811 Direct
2016-02-01 Common Stock F 3307 $79.10 Disposed 82504 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-01 Restricted Stock Unit $ M 7252 Disposed 2016-02-01 Common Stock (7252.0) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.